Relationship between HBV DNA level and pathological changes of liver tissue in HBeAg-negative patients with chronic HBV infection
-
摘要:
目的分析HBeAg阴性、ALT正常的HBV感染者HBV DNA水平与肝组织病理的关系。方法 89例HBeAg阴性慢性HBV感染者均接受肝组织穿刺病理学检查,并行肝炎病毒标志物、血清HBV标志物和HBV DNA检测,分析其HBV DNA水平与肝组织病理的关系。组间比较采用单因素方差分析,相关性分析采用Spearman等级相关。结果 89例患者的肝组织病理结果大部分异常,其中肝组织炎症分级≥G2者70例,占78.6%;纤维化分期≥S2者66例,占74.2%。不同肝组织炎症活动度分级患者之间的HBV DNA定量有明显的差别(F=2.678,P<0.05),而且二者呈正相关(rs=0.327,P<0.01);不同肝纤维化分期患者之间的HBV DNA定量也有明显的差别(F=2.625,P<0.05),而且二者呈正相关(rs=0.314,P<0.01)。结论 HBeAg阴性的慢性HBV感染者血清HBV DNA定量与肝组织病理损伤程度具有良好的一致性,如HBeAg阴性慢性HBV感染者HBV DNA滴度明显升高,应及早进行肝脏穿刺病理检查,以明确诊断并指导抗病毒治疗。
Abstract:Objective To analyze the relationship between hepatitis B virus (HBV) DNA level and pathological changes of liver tissue in HBeAg-negative patients with chronic HBV infection.Methods Eighty-nine HBeAg-negative patients with chronic HBV infection underwent liver biopsy and quantification of hepatitis virus markers, HBV markers, and HBV DNA in serum.The relationship between HBV DNA level and pathological changes of liver tissue was analyzed.One-way analysis of variance was used for comparison between groups;the Spearman rank correlation test was used for correlation analysis.Results Most of the 89 patients had abnormal liver pathology;of all patients, 70 (78.6%) had grade ≥2 liver tissue inflammation, and 66 (74.2%) had stage ≥2 liver fibrosis.There were significant differences in HBV DNA level among patients with different grades of liver tissue inflammation (F=2.678, P<0.05) , and HBV DNA level was positively correlated with the grade of liver tissue inflammation (rs=0.327, P<0.01) .There were significant differences in HBV DNA level among patients with different stages of liver fibrosis (F= 2.625, P<0.05) , and HBV DNA level was positively correlated with the stage of liver fibrosis (rs=0.314, P<0.01) .Conclusion There is a positive correlation between serum HBV DNA level and the degree of pathological damage of liver tissue in HBeAg-negative patients with chronic HBV infection.For the HBeAg-negative patients with chronic HBV infection who have significantly elevated HBV DNA level, liver biopsy should be performed in time for confirmed diagnosis and antiviral therapy.
-
Key words:
- hepatitis B virus /
- hepatitis B e antigens /
- biopsy /
- needle
-
[1]Saikia N, Talukdar R, Mazumder S, et al.Management of patientswith HBeAg-negative chronic B[J].Postgrad Med J, 2007, 83 (975) :32-39. [2]Brunetto MR, Oliveri F, Coco B, et al.Outcome of chronic anti-HBe positive chronic hepatitis B in alpha interferon treated and un-treated patients a long term cohort study[J].J Hepatol, 2002, 32 (6) :263-270. [3]Guo F, Ma H, Wei L, et al.Nine-year sutudy of HBeAg-nega-tive chronic hepatitis B[J].Chin J Exp Clin Virol, 2006, 20 (4) :370-372. (in Chinese) 郭芳, 马慧, 魏来, 等.HBeAg阴性慢性乙型肝炎9年前瞻性研究[J].中华实验和临床病毒学杂志, 2006, 20 (4) :370-372. [4]Hadziyannis S, Tassopoulos N, Chang TT, et al.Three year studyof adefovir dipivoxil (ADV) demonstrates sustained efficacy in pre-sumed precore mutant chronic hepatitis B (CHB) pttients in a longterm safety and efficacy study (LTSES) [J].J Hepatol, 2004, 40 (Suppl 1) :S17. [5]Chinese Society of Infectious Diseases and Parasitology and ChineseSociety of Hepatology of Chinese Medical Association.Preventionand treatment of viral hepatitis[J].Chin J Hepatol, 2000, 8 (6) :324-329. (in Chinese) 中华医学会传染病与寄生虫病学分会、肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志, 2000, 8 (6) :324-329. [6]Hadziyannis SJ, Vassilopoulos D.Hepatitis B e antigen-negativechronic hepatitis B[J].Hepatology, 2001, 34 (4 Pt 1) :617-624. [7]Lok AS, McMahon BJ.Chronic hepatitis B[J].Hepatology, 2001, 34 (6) :1225-1241. [8]Yang CG, Yu YC, Chen JJ, et al.A comparison of clinical and vir-ological characteristics of 1686 cases of HBeAg-negative andHBeAg-positive chronic hepatitis B[J].Chin J Intern Med, 2005, 44 (9) :648-651. (in Chinese) 杨创国, 于乐成, 陈金军, 等.1686例慢性乙型肝炎中HBeAg阴性与阳性患者临床和病毒学特点比较分析[J].中华内科杂志, 2005, 44 (9) :648-651. [9]Asahina Y, Izumi N, Uchihara M, et al.Core promoter/pre-coermutations are associated with lamivudine-induced HBeAg loss inchronic hepatitis B with genotype C[J].J Hepatol, 2003, 39 (6) :1063-1069. [10]Jiang B, Zong CG, Jiang XQ, et al.Clinical analysis of hapatitis B vi-rus precore region nucleartide 1896 mutations[J].Chin J Lab Diagn, 2009, 13 (3) :340-342. (in Chinese) 姜斌, 宗成国, 蒋雪芹, 等.乙肝病毒前C基因区1896位点变异的实验研究[J].中国实验诊断学, 2009, 13 (3) :340-342. [11]Li CX, Xu GH, Pan HQ, et al.Clinical differences betweenHBeAg-Positive and-negative chronic hepatitis B patients over40-years-old[J].J Clin Hepatol, 2012, 28 (6) :425-427. (in Chinese) 李春霞, 徐光华, 潘怀强, 等.40岁以上HBeAg阳性和阴性慢性乙型肝炎病毒感染者的临床特点比较[J].临床肝胆病杂志, 2012, 28 (6) :425-427. [12]Zhuang L, You J, Lei H, et al.Study of liver pathologyin mild ALT-elevated chronic hepatitis B patients with different HBV DNA lev-els[J].J Clin Hepatol, 2011, 27 (12) :1278-1281. (in Chi-nese) 庄林, 游晶, 雷华, 等.ALT轻度升高、HBV DNA水平不同的慢性乙型肝炎患者肝组织学差异探讨[J].临床肝胆病杂志, 2011, 27 (12) :1278-1281.
计量
- 文章访问数: 3234
- HTML全文浏览量: 11
- PDF下载量: 707
- 被引次数: 0